Two kinds of cancer drugs used together, and what it means for brain tumors
Original title: Dual VEGF and PD-(L)1 Blockade: Facts and Hopes.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a summary of where the science stands, not a new result.
The short version
This drug pairing helps in some cancers, but not in glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary so far.
What was studied. Experts reviewed past studies of two drug types given together. One type blocks the growth of blood vessels that feed tumors. The other helps the immune system fight cancer.
What they found. Given together, these drugs are approved for some advanced cancers. Those include kidney cancer, liver cancer, non-small cell lung cancer, and cancer of the uterus lining. In colorectal cancer and glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary, the results stay limited, and the authors call them disappointing.
What this means, and what it doesn't
What it could mean: For now, this pairing is not a treatment you can get for a brain tumor. Researchers are looking at new ways to make it work better.
What it doesn't mean: This is not a new study result. It is a summary of where the science stands today. It does not mean this pairing works for brain tumors, because so far it has not. It is not a cure, and it is not part of everyday brain tumor care.
Source: PubMed, October 26, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.